IC50 | 1700 nM | Cyclin-dependent kinase 6 | Q00534 | |
Others | 21 % | Serine/threonine-protein kinase PIM1 | P11309 | |
Others | 16 % | Serine/threonine-protein kinase PIM1 | P11309 | |
IC50 | 30 ug/ml | Epidermal growth factor receptor erbB1 | P00533 | |
Others | 12 % | Phosphodiesterase 5A | O76074 | |
IC50 | 10000 nM | Cytochrome P450 19A1 | P11511 | |
Others | 94 % | Canalicular multispecific organic anion transporter 1 | Q92887 | |
Others | 8.7 % | DNA topoisomerase II alpha | P11388 | |
Others | 1.6 | DNA topoisomerase II alpha | P11388 | |
Others | 60 % | DNA topoisomerase II alpha | P11388 | |
Others | 10 % | Estradiol 17-beta-dehydrogenase 1 | P14061 | |
Others | 25.2 % | Estradiol 17-beta-dehydrogenase 2 | P37059 | |
IC50 | 710 nM | Estradiol 17-beta-dehydrogenase 1 | P14061 | |
IC50 | 20000 nM | Estradiol 17-beta-dehydrogenase 2 | P37059 | |
IC50 | 800 nM | Casein kinase II alpha | P68400 | |
IC50 | 5200 nM | Androgen Receptor | P10275 | |
Ki | 37400 nM | Butyrylcholinesterase | P06276 | |
Ki | 121600 nM | Acetylcholinesterase | P22303 | |
Others | 1.9 | Peroxisome proliferator-activated receptor gamma | P37231 | |
Others | 5.4 | Peroxisome proliferator-activated receptor gamma | P37231 | |
Others | 2 | Peroxisome proliferator-activated receptor alpha | Q07869 | |
Others | 2.3 | Peroxisome proliferator-activated receptor alpha | Q07869 | |
IC50 | 570000 nM | Sialidase 2 | Q9Y3R4 | |
IC50 | 900 nM | Cytochrome P450 19A1 | P11511 | |
IC50 | 795 nM | Cytochrome P450 1A2 | P05177 | |
IC50 | 427 nM | Cytochrome P450 1A1 | P04798 | |
IC50 | 25 nM | Cytochrome P450 1B1 | Q16678 | |
Potency | 11220.2 nM | Prelamin-A/C | P02545 | |
Potency | 50118.7 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 12589.3 nM | Prelamin-A/C | P02545 | |
Potency | 19952.6 nM | Nuclear factor NF-kappa-B p105 subunit | P19838 | |
Potency | 31622.8 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 11220.2 nM | Lysine-specific demethylase 4D-like | B2RXH2 | |
Potency | 31622.8 nM | Hemoglobin beta chain | P68871 | |
Potency | 22387.2 nM | Survival motor neuron protein | Q16637 | |
Potency | 35481.3 nM | Survival motor neuron protein | Q16637 | |
Potency | 14125.4 nM | Survival motor neuron protein | Q16637 | |
Potency | 14125.4 nM | Survival motor neuron protein | Q16637 | |
Potency | 25118.9 nM | Survival motor neuron protein | Q16637 | |
Potency | 3981.1 nM | Thyroid stimulating hormone receptor | P16473 | |
Potency | 8912.5 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 1778.3 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 7079.5 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 25118.9 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 19952.6 nM | Cytochrome P450 2C19 | P33261 | |
Potency | 7943.3 nM | Cytochrome P450 2C19 | P33261 | |
Potency | 39810.7 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 10000 nM | Microtubule-associated protein tau | P10636 | |
Potency | 3162.3 nM | Microtubule-associated protein tau | P10636 | |
Potency | 10000 nM | Microtubule-associated protein tau | P10636 | |
Potency | 15848.9 nM | Microtubule-associated protein tau | P10636 | |
Potency | 8912.5 nM | Microtubule-associated protein tau | P10636 | |
Potency | 25118.9 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 1995.3 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 12589.3 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 12589.3 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 12589.3 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 1778.3 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 6309.6 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 10000 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 60119.8 nM | Peripheral myelin protein 22 | Q01453 | |
Potency | 3162.3 nM | Pyruvate kinase isozymes M1/M2 | P14618 | |
Potency | 12589.3 nM | Prelamin-A/C | P02545 | |
Potency | 5011.9 nM | Arachidonate 15-lipoxygenase | P16050 | |
Potency | 12589.3 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 1995.3 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 35481.3 nM | Microtubule-associated protein tau | P10636 | |
Potency | 19952.6 nM | MAP kinase ERK2 | P28482 | |
Potency | 3162.3 nM | Pyruvate kinase isozymes M1/M2 | P14618 | |
Potency | 19952.6 nM | Nuclear factor NF-kappa-B p105 subunit | P19838 | |
Potency | 5804.8 nM | Niemann-Pick C1 protein | O15118 | |
Potency | 39810.7 nM | DNA-(apurinic or apyrimidinic site) lyase | P27695 | |
Potency | 10000 nM | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | |
Potency | 28183.8 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 3548.1 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 22387.2 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 31622.8 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 501.2 nM | Thrombopoietin | P40225 | |
Potency | 31622.8 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 3981.1 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 5011.9 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 398.1 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 15848.9 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 25118.9 nM | Neuropeptide S receptor | Q6W5P4 | |
Potency | 39810.7 nM | Cytochrome P450 2D6 | P10635 | |
Potency | 7943.3 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 1258.9 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 3162.3 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 12589.3 nM | Cytochrome P450 2D6 | P10635 | |
Potency | 5011.9 nM | Cytochrome P450 2C9 | P11712 | |
Potency | 7943.3 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 1258.9 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 12589.3 nM | Geminin | O75496 | |
Potency | 31622.8 nM | Cytochrome P450 2C9 | P11712 | |
Potency | 3162.3 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 501.2 nM | Thrombopoietin | P40225 | |
Potency | 11220.2 nM | Beta-glucocerebrosidase | P04062 | |
Potency | 8912.5 nM | Beta-glucocerebrosidase | P04062 | |
Potency | 3262.9 nM | ATPase family AAA domain-containing protein 5 | Q96QE3 | |
Potency | 19952.6 nM | Beta-glucocerebrosidase | P04062 | |
Potency | 12589.3 nM | Beta-glucocerebrosidase | P04062 | |
Potency | 7079.5 nM | Beta-glucocerebrosidase | P04062 | |
Potency | 461.1 nM | Nuclear factor erythroid 2-related factor 2 | Q16236 | |
Potency | 794.3 nM | M-phase phosphoprotein 8 | Q99549 | |
Potency | 37933 nM | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Q13526 | |
Potency | 2058.8 nM | ATPase family AAA domain-containing protein 5 | Q96QE3 | |
Others | 88 pm/min/mg | UDP-glucuronosyltransferase 1-1 | P22309 | |
Others | 164 pm/min/mg | UDP-glucuronosyltransferase 1-10 | Q9HAW8 | |
Others | 508 pm/min/mg | UDP-glucuronosyltransferase 1-3 | P35503 | |
Others | 0 pm/min/mg | UDP-glucuronosyltransferase 1A4 | P22310 | |
Others | 845 pm/min/mg | UDP-glucuronosyltransferase 1-8 | Q9HAW9 | |
Others | 574 pm/min/mg | UDP-glucuronosyltransferase 1-8 | Q9HAW9 | |
Others | 18 pm/min/mg | UDP-glucuronosyltransferase 2B15 | P54855 | |
IC50 | 38500 nM | Beta-secretase 1 | P56817 | |
Potency | 35481.3 nM | Aryl hydrocarbon receptor | P35869 | |
Potency | 28183.8 nM | Aryl hydrocarbon receptor | P35869 | |
Potency | 35481.3 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 33491.5 nM | Nuclear factor erythroid 2-related factor 2 | Q16236 | |
Potency | 24336.5 nM | Nuclear factor erythroid 2-related factor 2 | Q16236 | |
Potency | 31622.8 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 35481.3 nM | Glutaminase kidney isoform, mitochondrial | O94925 | |
Potency | 11220.2 nM | Ataxin-2 | Q99700 | |
Potency | 22387.2 nM | Breast cancer type 1 susceptibility protein | P38398 | |
Potency | 66824.2 nM | Interleukin-8 | P10145 | |
Potency | 4216.3 nM | Nuclear receptor ROR-gamma | P51449 | |
EC50 | 3000 nM | Tyrosine-protein kinase SYK | P43405 | |
IC50 | 1700 nM | Cyclin-dependent kinase 6 | Q00534 | |
IC50 | 1900 nM | Glycogen synthase kinase-3 beta | P49841 | |
IC50 | 38500 nM | Beta-secretase 1 | P56817 | |
IC50 | 12 nM | Acetylcholinesterase | P22303 | |
Others | 6.3 | Peroxisome proliferator-activated receptor delta | Q03181 | |
Others | 3.9 | Peroxisome proliferator-activated receptor delta | Q03181 | |
IC50 | 1450 nM | Tyrosine-protein kinase receptor FLT3 | P36888 | |
IC50 | 100000 nM | Poly [ADP-ribose] polymerase-1 | P09874 | |
IC50 | 2951.21 nM | Tankyrase-2 | Q9H2K2 | |
IC50 | 2900 nM | Tankyrase-2 | Q9H2K2 | |
IC50 | 3162.28 nM | Tankyrase-1 | O95271 | |
IC50 | 3100 nM | Tankyrase-1 | O95271 | |
Others | 50 % | Arachidonate 5-lipoxygenase | P09917 | |
Ki | 81000 nM | Cystic fibrosis transmembrane conductance regulator | P13569 | |
EC50 | 9000 nM | Cystic fibrosis transmembrane conductance regulator | P13569 | |
Ki | 520 nM | Xanthine dehydrogenase | P47989 | |
IC50 | 3200 nM | Xanthine dehydrogenase | P47989 | |
IC50 | 18000 nM | Transthyretin | P02766 | |
Kd | 250 nM | Transthyretin | P02766 | |
IC50 | 31000 nM | Death-associated protein kinase 1 | P53355 | |
IC50 | 1200 nM | Cytochrome P450 19A1 | P11511 | |
Others | 84 % | Isocitrate dehydrogenase [NADP] cytoplasmic | O75874 | |
Others | 97.4 % | Isocitrate dehydrogenase [NADP] cytoplasmic | O75874 | |
Others | 34 % | Aldo-keto reductase family 1 member B10 | O60218 | |
Others | 25 % | Aldo-keto reductase family 1 member B10 | O60218 | |
IC50 | 37100 nM | Aldo-keto reductase family 1 member B10 | O60218 | |
Ki | 6000 nM | Aldo-keto reductase family 1 member B10 | O60218 | |
IC50 | 11900 nM | Aldose reductase | P15121 | |
IC50 | 6600 nM | Aldo-keto reductase family 1 member B10 | O60218 | |
Others | 10 | Aldo-keto reductase family 1 member B10 | O60218 | |
Others | 21.3 % | Insulin receptor | P06213 | |
Others | 19.9 % | Insulin receptor | P06213 | |
Others | 80.1 % | Insulin receptor | P06213 | |
Others | 10.7 % | Insulin receptor | P06213 | |
Others | 75.2 % | Glutaminyl-peptide cyclotransferase | Q16769 | |